Annual ROE
637.82%
+895.44%+347.58%
31 December 2023
Summary:
Qualigen Therapeutics annual return on equity is currently 637.82%, with the most recent change of +895.44% (+347.58%) on 31 December 2023. During the last 3 years, it has risen by +876.67% (+367.04%). QLGN annual ROE is now at all-time high.QLGN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
260.83%
-75.84%-22.53%
30 September 2024
Summary:
Qualigen Therapeutics quarterly return on equity is currently 260.83%, with the most recent change of -75.84% (-22.53%) on 30 September 2024. Over the past year, it has increased by +815.74% (+147.00%). QLGN quarterly ROE is now -70.60% below its all-time high of 887.17%, reached on 31 March 2024.QLGN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +347.6% | +147.0% |
| 3 y3 years | +367.0% | +160.1% |
| 5 y5 years | - | - |
QLGN ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +347.6% | -70.6% | +115.3% |
| 5 y | 5 years | at high | +347.6% | -70.6% | +100.5% |
| alltime | all time | at high | +347.6% | -70.6% | +100.5% |
Qualigen Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 260.83%(-22.5%) |
| June 2024 | - | 336.67%(-62.1%) |
| Mar 2024 | - | 887.17%(-152.2%) |
| Dec 2023 | 637.82%(-347.6%) | -1698.74%(+206.1%) |
| Sept 2023 | - | -554.91%(+108.3%) |
| June 2023 | - | -266.38%(+42.0%) |
| Mar 2023 | - | -187.63%(+19.2%) |
| Dec 2022 | -257.62% | -157.38%(+35.3%) |
| Sept 2022 | - | -116.30%(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | -109.54%(-10.4%) |
| Mar 2022 | - | -122.26%(-20.6%) |
| Dec 2021 | -102.68%(-57.0%) | -153.99%(-64.5%) |
| Sept 2021 | - | -433.99%(-62.2%) |
| June 2021 | - | -1148.93%(-97.6%) |
| Mar 2021 | - | -48.77 K%(<-9900.0%) |
| Dec 2020 | -238.85% | - |
| Sept 2020 | - | 332.79%(+131.2%) |
| June 2020 | - | 143.96% |
FAQ
- What is Qualigen Therapeutics annual return on equity?
- What is the all time high annual ROE for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual ROE year-on-year change?
- What is Qualigen Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly ROE year-on-year change?
What is Qualigen Therapeutics annual return on equity?
The current annual ROE of QLGN is 637.82%
What is the all time high annual ROE for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual return on equity is 637.82%
What is Qualigen Therapeutics annual ROE year-on-year change?
Over the past year, QLGN annual return on equity has changed by +895.44% (+347.58%)
What is Qualigen Therapeutics quarterly return on equity?
The current quarterly ROE of QLGN is 260.83%
What is the all time high quarterly ROE for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly return on equity is 887.17%
What is Qualigen Therapeutics quarterly ROE year-on-year change?
Over the past year, QLGN quarterly return on equity has changed by +815.74% (+147.00%)